Production (Stage)
InterCure Ltd.
INCR
$1.52
$0.021.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | 12/31/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -99.55% | -37.03% | 102.74% |
| Total Depreciation and Amortization | -- | -- | -74.05% | -0.26% | 36.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | 1,049.39% | -85.12% | -118.28% |
| Change in Net Operating Assets | -- | -- | -886.92% | -32.07% | -99.99% |
| Cash from Operations | -- | -- | -198.46% | -113.10% | -109.16% |
| Capital Expenditure | -- | -- | 96.71% | 56.65% | 30.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 67.69% | -27.66% | 30.67% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 92.12% | -46.77% | -283.85% |
| Cash from Investing | -- | -- | 90.24% | -20.07% | -98.64% |
| Total Debt Issued | -- | -- | -96.28% | -1.85% | 157.75% |
| Total Debt Repaid | -- | -- | 48.28% | -70.87% | -1,428.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 77.40% | -274.40% | -252.28% |
| Cash from Financing | -- | -- | -147.46% | -92.71% | -80.26% |
| Foreign Exchange rate Adjustments | -- | -- | -98.75% | -138.25% | 282.23% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -428.59% | -614.80% | -156.00% |